Form 4: NEXGEL Director Scott Robert Henry Sells 3,000 Shares Under 10b5-1 Trading Plan
SEC Form 4
Director Scott Robert Henry of NEXGEL, INC. sold 3,000 shares of common stock on December 20, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On December 20, 2024, Scott Robert Henry, a director of NEXGEL, INC., sold 3,000 shares of common stock.
- The sale was executed under a Rule 10b5-1 trading plan.
- The shares were sold at a weighted average price of $4.6449.
- The price range for the sales was between $4.52 and $4.78 per share.
- Following the transaction, Henry directly owns 144,553 shares of NEXGEL, INC.
- The shares sold were originally purchased in the open market on September 16, 2022, and were not part of recent registered direct offerings.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine transaction under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.
Industry Context
Sales by insiders are a common occurrence and are often viewed in the context of the individual's financial planning. The use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The sale of shares by a director could have a minor psychological impact on shareholders, but the use of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 09/16/2022 | Date the shares sold were originally purchased in the open market. |
| 12/20/2024 | Date of the transaction (sale of shares). |
| 12/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.